Daré will host a conference call and live webcast today, November 14, 2024, at 4:30 p.m. Eastern Time to review financial ...

Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate - pivotal Phase 3 contra ...

Metronidazole (Flagyl) 500 mg orally twice a day for 7 days Metronidazole (Flagyl) 250 mg orally three times a day for 7 days Clindamycin ... h until delivery GBS = Group B streptococcus; IV ...

During your period, menopause, or even stressful times, hormonal imbalances can cause acne, dryness, and wrinkles.

The global necrotizing fasciitis treatment market is poised for significant growth, with a projected valuation of USD 2.9 billion in 2024 and an anticipated increase to USD 4.5 billion by the end of ...

Cefazolin* (Ancef) 2 g IV initial dose then 1 g IV every 8 h until delivery Clindamycin † 900 mg IV ... 1 g IV every 12 h until delivery GBS = Group B streptococcus; IV = intravenously; PCN ...

EMERYVILLE, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) announced today it has entered into a $15 million royalty monetization arrangement with Twist ...

This financial move aims to bolster Dare's development of its investigational products. The company's portfolio includes XACIATO (clindamycin phosphate) vaginal gel 2%, already FDA-approved and ...

XOMA Royalty (XOMA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. XOMA Royalty ...

Gentamicin is used to treat serious bacterial infections. It is an antibiotic that belongs to a group of medicines called aminoglycoside antibiotics. It works by killing bacteria or preventing ...